Literature DB >> 23860603

Remnant liver volume-based predictors of postoperative liver dysfunction after hepatectomy: analysis of 625 consecutive patients from a single institution.

Hirohisa Okabe1, Toru Beppu, Akira Chikamoto, Hiromitsu Hayashi, Morikatsu Yoshida, Toshiro Masuda, Katsunori Imai, Kosuke Mima, Shigeki Nakagawa, Hideyuki Kuroki, Hidetoshi Nitta, Takatoshi Ishiko, Daisuke Hashimoto, Yasuyuki Yamashita, Hideo Baba.   

Abstract

BACKGROUND: During hepatic resection, accurate estimation of remnant liver volume and hepatic function is crucial for avoiding postoperative liver failure. The purpose of this study was to identify preoperative factors related to postoperative liver dysfunction according to the percentage of future liver remnant volume (%FLR).
METHODS: A total of 625 patients who underwent hepatectomy were enrolled in this study. Total bilirubin level >50 μmol/L and/or prothrombin time index <50 % on postoperative day 5 were used as criteria for postoperative liver dysfunction (PLD). Patients were classified into 3 groups according to the %FLR: 35-60 (n = 116), 60-80 (n = 157), and >80 (n = 351). Multivariate logistic regression analysis was performed to identify factors related to postoperative liver dysfunction in each group.
RESULTS: Among the patients with 35-80 %FLR, the morbidity and mortality rates were significantly higher in patients with PLD than in patients without PLD. There was no postoperative death in patients with >80 %FLR . Multivariate analysis showed that PLD was associated with receptor index (LHL15) ≤0.93 (odds ratio [OR] = 7.96) in patients with 35-60 %FLR. The sensitivity and specificity for PLD were 87.5 and 96.1 %, respectively. In patients with 60-80 %FLR, PLD was associated with platelet count <10.0 × 10(4)/mL (OR = 6.12). The sensitivity and specificity for PLD were 73.3 and 96.2 %, respectively.
CONCLUSION: LHL15 ≤0.93 and platelet count <10.0 × 10(4)/mL are pivotal indicators for predicting PLD in patients with 35-60 %FLR and 60-80 %FLR, respectively.

Entities:  

Mesh:

Year:  2013        PMID: 23860603     DOI: 10.1007/s10147-013-0591-0

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  32 in total

1.  Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy.

Authors:  H Lau; K Man; S T Fan; W C Yu; C M Lo; J Wong
Journal:  Br J Surg       Date:  1997-09       Impact factor: 6.939

Review 2.  Strategies for safer liver surgery and partial liver transplantation.

Authors:  Pierre-Alain Clavien; Henrik Petrowsky; Michelle L DeOliveira; Rolf Graf
Journal:  N Engl J Med       Date:  2007-04-12       Impact factor: 91.245

3.  [Phase II clinical study on 99mTc-GSA, a new agent for functional imaging of the liver].

Authors:  K Torizuka; S K Ha-Kawa; M Kudo; S Kitagawa; Y Kubota; Y Tanaka; M Hino; K Ikekubo
Journal:  Kaku Igaku       Date:  1992-01

4.  Preoperative portal vein embolization (PVE) for patients with hepatocellular carcinoma can improve resectability and may improve disease-free survival.

Authors:  Hirohisa Okabe; Toru Beppu; Takatoshi Ishiko; Toshiro Masuda; Hiromitsu Hayashi; Ryu Otao; Horlad Hasita; Kazutoshi Okabe; Shinichi Sugiyama; Hideo Baba
Journal:  J Surg Oncol       Date:  2011-04-25       Impact factor: 3.454

Review 5.  Surgery and portal hypertension.

Authors:  C G Child; J G Turcotte
Journal:  Major Probl Clin Surg       Date:  1964

6.  Clinical usefulness of scintigraphy with 99mTc-galactosyl-human serum albumin for prognosis of cirrhosis of the liver.

Authors:  N Sasaki; S Shiomi; Y Iwata; S Nishiguchi; T Kuroki; J Kawabe; H Ochi
Journal:  J Nucl Med       Date:  1999-10       Impact factor: 10.057

7.  Preoperative portal vein embolization for extended hepatectomy.

Authors:  Alan W Hemming; Alan I Reed; Richard J Howard; Shiro Fujita; Steven N Hochwald; James G Caridi; Irvin F Hawkins; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

8.  Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.

Authors:  J Bruix; A Castells; J Bosch; F Feu; J Fuster; J C Garcia-Pagan; J Visa; C Bru; J Rodés
Journal:  Gastroenterology       Date:  1996-10       Impact factor: 22.682

9.  Hyperasialoglycoproteinemia in patients with chronic liver diseases and/or liver cell carcinoma. Asialoglycoprotein receptor in cirrhosis and liver cell carcinoma.

Authors:  T Sawamura; H Nakada; H Hazama; Y Shiozaki; Y Sameshima; Y Tashiro
Journal:  Gastroenterology       Date:  1984-12       Impact factor: 22.682

10.  A new liver functional study using Tc-99m DTPA-galactosyl human serum albumin: evaluation of the validity of several functional parameters.

Authors:  K Koizumi; G Uchiyama; T Arai; T Ainoda; Y Yoda
Journal:  Ann Nucl Med       Date:  1992-05       Impact factor: 2.668

View more
  7 in total

1.  Anatomic resection of liver segments 6-8 for hepatocellular carcinoma.

Authors:  Chang-Ku Jia; Jie Weng; You-Ke Chen; Yu Fu
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

2.  Effect of branched-chain amino acid supplementation on functional liver regeneration in patients undergoing portal vein embolization and sequential hepatectomy: a randomized controlled trial.

Authors:  Toru Beppu; Hidetoshi Nitta; Hiromitsu Hayashi; Katsunori Imai; Hirohisa Okabe; Shigeki Nakagawa; Daisuke Hashimoto; Akira Chikamoto; Takatoshi Ishiko; Morikatsu Yoshida; Yasuyuki Yamashita; Hideo Baba
Journal:  J Gastroenterol       Date:  2015-04-08       Impact factor: 7.527

Review 3.  [Liver transection: modern procedure: Technique, results and costs].

Authors:  H Bruns; M W Büchler; P Schemmer
Journal:  Chirurg       Date:  2015-06       Impact factor: 0.955

4.  A comprehensive method for predicting fatal liver failure of patients with liver cancer resection.

Authors:  Jiangfa Li; Biao Lei; Xingju Nie; Linku Lin; Syed Abdul Tahir; Wuxiang Shi; Junfei Jin; Songqing He
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

5.  Integration of Child-Pugh score with future liver remnant yields improved prediction of liver dysfunction risk for HBV-related hepatocellular carcinoma following hepatic resection.

Authors:  Heng Zou; Yiming Tao; Zhi-Ming Wang
Journal:  Oncol Lett       Date:  2017-03-27       Impact factor: 2.967

6.  Right hepatectomy with preservation of the entire caudate lobe in patients with metastatic liver tumors: a case of a new hepatectomy technique and treatment strategy for patients with marginal liver function.

Authors:  Hiroyuki Kato; Yukio Asano; Masahiro Ito; Satoshi Arakawa; Norihiko Kawabe; Masahiro Shimura; Daisuke Koike; Chihiro Hayashi; Takayuki Ochi; Kenshiro Kamio; Toki Kawai; Hironobu Yasuoka; Takahiko Higashiguchi; Akihiko Horiguchi
Journal:  BMC Surg       Date:  2022-01-15       Impact factor: 2.102

Review 7.  Oncological benefits of portal vein embolization for patients with hepatocellular carcinoma.

Authors:  Toru Beppu; Kensuke Yamamura; Hirohisa Okabe; Katsunori Imai; Hiromitsu Hayashi
Journal:  Ann Gastroenterol Surg       Date:  2020-12-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.